Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 The Use of Tissue-equivalent Based on Cultured Cells for Healing Skin Blemishes

NCT01884831 is registered in ClinicalTrials.gov with Ural State Medical University as lead sponsor.

NCT NCT01884831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01884831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 The Use of Tissue-equivalent Based on Cultured Cells for Healing Skin Blemishes
Lead sponsor
Ural State Medical University
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2014
Completion date
July 31, 2018
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns, neurotrophic ulcers